Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q1 FY22 results · Apr–Jun 2021
Krishna Institute of Medical Sciences reported revenue from operations of ₹473.18 crore and net profit of ₹92.03 crore for Q1 FY22 (Apr–Jun 2021), on a consolidated basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 473.18 | — | — | 0.00 | — |
| Other income | 4.27 | — | — | 0.00 | — |
| Total income | 477.45 | — | — | 0.00 | — |
| Profit before tax | 124.53 | — | — | 0.00 | — |
| Net profit for the period | 92.03 | — | — | 0.00 | — |
| Attributable to shareholders of the company | 89.13 | — | — | — | — |
| EPS, basic (₹) | 11.48 | — | — | 0.00 | — |
| Net margin (%) | 19.4 | — | — |
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 331.51 | — | — | 0.00 | — |
| Other income | 4.02 | — | — | 0.00 | — |
| Total income | 335.53 | — | — | 0.00 | — |
| Profit before tax | 102.13 | — | — | 0.00 | — |
| Net profit for the period | 76.16 | — | — | 0.00 | — |
| EPS, basic (₹) | 9.81 | — | — | 0.00 | — |
| Net margin (%) | 23.0 | — | — |
Consolidated
- Filed with BSE
- 11 Aug 2021, 17:12 IST
- Board meeting
- 10 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2021, 17:12 IST
- Board meeting
- 10 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE